Skip to main content

Table 3 Risk behavior reported at the first and last test in individuals undergoing repeat HIV testing: individuals with <180 days between tests were excluded

From: Repeat HIV-testing is associated with an increase in behavioral risk among men who have sex with men: a cohort study

   2–3 HIV tests (n = 1384; 47 HIV+) median time first/last test 503 days (IQR, 317–845 days) 4–5 HIV tests (n = 565; 22 HIV+) median time first/last test 844 days (IQR, 567–1229 days) 6 or more tests (n = 508; 18 HIV+) median time first/last test 1333 days (IQR, 920–1705 days)
Risk factor/risk behavior (within 12 months prior to test) Prevalence of AEH per individuals that reported the risk a First Test Last Test   First Test Last Test   First Test Last Test  
Individuals reporting risk (n,%) Individuals reporting risk (n, %) Difference in percentage, relative (absolute) P value b Individuals reporting risk (n, %) Individuals reporting risk (n, %) Difference in percentage, relative (absolute) P value b Individuals reporting risk (n, %) Individuals reporting risk (n, %) Difference in percentage, relative (absolute) P value b
10 or more male partners 3.8 % 456/1384 (32.95 %) 504/1384 (36.42 %) +10.53 % (+3.47 %) 0.011 193/565 (34.16 %) 224/565 (39.65 %) +16.07 % (+5.49 %) 0.012 198/508 (38.98 %) 223/508 (43.90 %) +12.62 % (+4.92 %) 0.054
CRAI and 10 or more male partners 5.5 % 255/1384 (18.43 %) 301/1384 (21.75 %) +18.01 % (+3.32 %) 0.006 101/565 (17.88 %) 132/565 (23.36 %) +30.65 % (+5.48 %) 0.004 116/508 (22.83 %) 130/508 (25.59 %) +12.09 % (+2.76 %) n.s.
CRAI with HIV positive male 7.8 % 46/1277 (3.60 %) 72/1335 (5.39 %) +49.72 % (+1.79 %) n.s. 18/526 (3.42 %) 32/551 (5.81 %) +69.88 % (+2.39 %) n.s. 8/446 (1.79 %) 52/495 (10.51 %) +487 % (+8.72 %) <0.001
CRAI with sex worker 7.7 % 5/1350 (0.37 %) 6/1364 (0.44 %) +10.45 % (+0.07 %) n.s. 1/555 (0.18 %) 2/561 (0.36 %) +100 % (+0.18 %) n.s. 1/489 (0.20 %) 4/502 (0.80 %) +300 % (+0.60 %) n.s.
CRAI with PWID 10.3 % 9/1350 (0.67 %) 17/1365 (1.25 %) +86.57 % (+0.58 %) n.s. 5/555 (0.90 %) 13/559 (2.33 %) +159 % (+1.43 %) n.s. 0/491 (0 %) 9/498 (1.81 %) +∞ (+1.81 %) 0.008
Any self-reported STI 4.6 % 155/1384 (11.20 %) 177/1384 (12.79 %) +14.20 % (+1.59 %) n.s. 64/565 (11.33 %) 87/565 (15.40 %) +35.92 % (+4.07 %) 0.040 91/508 (17.91 %) 77/508 (15.16 %) −15.35 % (−2.75 %) n.s.
IDU with shared needles 7.8 % 4/1384 (0.29 %) 9/1384 (0.65 %) +124 % (+0.36 %) n.s. 2/565 (0.35 %) 5/555 (0.90 %) +157 % (+0.55 %) n.s. 0/508 (0 %) 3/508 (0.59 %) +∞ (+0.59 %) n.s.
Methamphetamine, not injected 6.2 % 77/1384 (5.56 %) 88/1384 (6.36 %) +14.39 % (+0.80 %) n.s. 28/565 (4.96 %) 35/565 (6.19 %) +24.79 % (+1.23 %) n.s. 26/508 (5.11 %) 38/508 (7.48 %) +46.38 % (+2.37 %) 0.090
Non-injection stimulant drug use c 3.3 % 318/1384 (22.98 %) 411/1384 (29.70 %) +29.24 % (+6.72 %) <0.001 130/565 (23.01 %) 166/565 (29.38 %) +27.58 % (+6.37 %) 0.002 96/508 (18.90 %) 163/508 (32.09 %) +69.79 % (+13.19 %) <0.001
  1. AEH, Acute and early HIV infection; CRAI, Condomless receptive anal intercourse; IQR, Interquartile range; IDU, Injection drug use; n.s., Not significant; PWID, Person who injects drugs; STI, Sexually transmitted infection; a Among whole MSM study population after exclusion of those with newly diagnosed chronic HIV infection
  2. b Calculated using McNemara test; P value displayed when below 0.1
  3. c i.e. Methamphetamine, cocaine, poppers, Gamma hydroxybutyrate, ketamine, ecstasy
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us